Back to Search
ALINE GOTTLIEB, MD, PHD
MD, PHD
Internal Medicine Physician
NPI: 1952042921IndividualAccepts Medicare
Education
OTHER
Class of 2015
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Research & Publications (20)
Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials.
PMID 29614243·J Am Acad Dermatol·2018
3-trial
Safety and Efficacy of a Fixed Combination Halobetasol and Tazarotene Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Pooled Analysis of Two Phase 3 Studies.
PMID 30124724·J Drugs Dermatol·2018
8-other
Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial.
PMID 27707593·J Am Acad Dermatol·2017
3-trial
Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects.
PMID 27113059·Am J Clin Dermatol·2016
6-review
CCL20 and IL22 Messenger RNA Expression After Adalimumab vs Methotrexate Treatment of Psoriasis: A Randomized Clinical Trial.
PMID 25946554·JAMA Dermatol·2015
4-observational
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).
PMID 18047523·Br J Dermatol·2008
4-observational
Mechanisms of action of etanercept in psoriasis.
PMID 17502868·J Investig Dermatol Symp Proc·2007
6-review
Induction of lesional and circulating leukocyte apoptosis by infliximab in a patient with moderate to severe psoriasis.
PMID 17039656·J Drugs Dermatol·2006
5-case
Etanercept induces apoptosis of dermal dendritic cells in psoriatic plaques of responding patients.
PMID 17010737·J Am Acad Dermatol·2006
8-other
TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques.
PMID 16081850·J Immunol·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
Via practice · 2 locations total
- Address
- 10150 SE 32ND AVE
MILWAUKIE, OR 97222 - Phone
- (503) 513-8641
Quick Facts
- NPI
- 1952042921
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 11
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile